| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Discount on subordinated debt | NaN | -1 | 155 | 307 |
| Stock compensation expense | NaN | 541 | 914 | 544 |
| Net income | 8,706 | 19,447 | 18,297 | 18,504 |
| Loss on sales of investment securities | NaN | NaN | NaN | 243 |
| Provision for credit losses | 1,594 | -839 | -434 | 2,570 |
| Depreciation | 1,493 | 1,363 | 1,187 | 2,305 |
| Amortization of intangibles | 1,300 | 930 | 944 | 1,172 |
| Net amortization of security discounts/premiums | -229 | -141 | -57 | -132 |
| Noncash operating lease expense | 795 | 725 | 784 | 1,335 |
| Amortization of finance lease right-of-use asset | 45 | 45 | 45 | 90 |
| Earnings on cash surrender value of life insurance | 705 | 609 | 605 | 765 |
| Mortgage loans originated for sale | 21,039 | 70,335 | 1,420 | 31,868 |
| Gain on sale of property, plant, and equipment | NaN | 41 | 0 | 10 |
| Proceeds from sales of mortgage loans originated for sale | 8,467 | 73,304 | 2,449 | 34,098 |
| Gain on sale of mortgage loans | 314 | 552 | 1,013 | 1,267 |
| Sba loans originated for sale | 2,783 | 1,643 | 0 | 1,783 |
| Proceeds from sales of sba loans originated for sale | 2,948 | 1,742 | 0 | 1,903 |
| Gain on sale of sba loans | 163 | 100 | 0 | 120 |
| Loss/(gain) on sale or write-down of foreclosed assets | 491 | 203 | 471 | -28 |
| Discount on subordinated debt | 0 | NaN | NaN | NaN |
| Accretion of loan fair value marks | 2,441 | NaN | NaN | NaN |
| Restricted stock compensation expense | 533 | NaN | NaN | NaN |
| Stock option expense | 132 | NaN | NaN | NaN |
| Deferred income tax expense | 1,309 | 6,513 | 5,927 | 1,451 |
| Increase/(decrease) in accrued interest receivable | -740 | -65 | 1,159 | -571 |
| Increase in other assets | -867 | 11,121 | -2,421 | -4,586 |
| Increase/(decrease) in accrued interest payable | 1,125 | -5,518 | 3,039 | -92 |
| Increase/(decrease) in operating lease liability | 1,700 | -762 | -827 | 4,928 |
| Increase/(decrease) in other liabilities | 4,544 | -242 | -4,404 | 2,310 |
| Net cash provided by operating activities | 14,455 | 13,258 | 26,275 | 40,502 |
| Proceeds from the sale of available-for-sale securities | NaN | 0 | NaN | NaN |
| Proceeds from the maturity or call of available-for-sale securities | 28,265 | 25,856 | 14,967 | 19,430 |
| Purchases of available-for-sale securities | 98,899 | 12,402 | 33,495 | 155,899 |
| Proceeds from the maturity or call of held-to-maturity securities | 6,342 | 6,767 | 9,881 | 18,295 |
| Stock dividends received on fhlb and other bank stock | NaN | 113 | 112 | 218 |
| Redemption of restricted investment in bank stock | 13,023 | NaN | NaN | NaN |
| (purchases)/reduction of restricted investment in bank stock | NaN | 952 | -261 | -133 |
| Purchases of restricted investment in bank stock | 15,528 | NaN | NaN | NaN |
| Net cash received/(paid) from acquisitions | NaN | 1 | -218,113 | NaN |
| Net cash received from acquisitions | -55,304 | NaN | NaN | 218,112 |
| Net increase in loans | 65,628 | 42,592 | -11,919 | -5,158 |
| Purchases of bank premises and equipment | 1,425 | 1,805 | 1,946 | 4,483 |
| Proceeds from the sale of premises and equipment | 0 | 232 | 0 | 120 |
| Proceeds from the sale of foreclosed assets | 168 | 1,819 | 0 | 72 |
| Proceeds from bank-owned life insurance | 2,022 | 273 | 360 | 444 |
| Earnings on bank-owned life insurance | 0 | 0 | NaN | NaN |
| Net change in investments in tax credits and other partnerships | -2,770 | -513 | -486 | -1,202 |
| Net cash provided by (used in) investing activities | 33,918 | -22,179 | 2,546 | 102,802 |
| Proceeds from long-term debt | NaN | 0 | NaN | NaN |
| Subordinated debt redemption | NaN | 37,150 | -1 | 8,131 |
| Proceeds from public offering of common stock | NaN | 0 | NaN | NaN |
| Exercise of stock options | NaN | 351 | 3,161 | 3,364 |
| Treasury stock purchased | NaN | 246 | 226 | 1,778 |
| Net change in short-term borrowings | NaN | NaN | NaN | -2,000 |
| Net increase in deposits | 9,393 | -128,057 | -106,944 | 139,977 |
| Common stock dividends paid | 6,237 | 5,082 | 4,551 | 8,527 |
| Proceeds from employee and director stock purchase plan stock issuance | 194 | 140 | 171 | 308 |
| Net change in finance lease liability | 37 | 37 | 37 | 72 |
| Proceeds from short-term borrowings | 453,300 | 20,833 | 222,750 | NaN |
| Repayment of short-term borrowings | 442,633 | 0 | 224,750 | NaN |
| Cash paid in lieu of fractional shares | NaN | NaN | NaN | 7 |
| Long-term debt repayment | 20,081 | 82 | 79 | 157 |
| Net cash (used in)/provided by financing activities | -6,101 | -149,330 | -108,497 | 122,977 |
| Net increase in cash and cash equivalents | 42,272 | -158,251 | -79,676 | 266,281 |
| Cash and cash equivalents, beginning of period | 98,918 | 257,169 | 70,564 | NaN |
| Cash and cash equivalents, end of period | 141,190 | 98,918 | 257,169 | NaN |
MID PENN BANCORP INC (MPB)
MID PENN BANCORP INC (MPB)